News

Carvedilol Better Prevents Cirrhosis Complications in Compensated and Decompensated Patients

A new study published in the Journal of Hepatology shows that carvedilol, a non-cardioselective beta-blocker, is more effective than traditional beta-blockers in preventing complications of cirrhosis,...

The Dreta de l’Eixample Primary Care Team (EAP) Joins IR Sant Pau to Strengthen Research in Primary Care

The Sant Pau Research Institute (IR Sant Pau), a health research institute (IIS) accredited by the Instituto de Salud Carlos III (ISCIII), continues its commitment to primary care research with the in...

Nanoligent, a Spin-Off from IR Sant Pau and UAB, Raises €12 Million to Bring a CXCR4-Targeted Nanodrug to the Clinic

Nanoligent, a spin-off from the Institut de Recerca Sant Pau (IR Sant Pau) and the Universitat Autnoma de Barcelona (UAB), has closed a €12 million funding round led by Inveready to advance the deve...

Dr. Íñigo Rodríguez Baz Receives Alzheimer’s Association Grant to Advance Dementia Diagnosis

Dr. Íñigo Rodríguez Baz, from the Neurobiology of Dementias Group at the Sant Pau Research Institute and the Memory Unit at Hospital Sant Pau, has been awarded a grant from the Alzheimer’s Associ...

Sant Pau Participates in an International Gene Therapy Trial for Wet Macular Degeneration

The Ophthalmology Department of Hospital de Sant Pau, together with the Ophthalmology Research Group of the Sant Pau Research Institute (IR Sant Pau), has recently participated in an international cli...